Cargando…
A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
Scopolamine hydrobromide (SH)-loaded microparticles were prepared from a colloidal fluid containing ionotropic-gelated chitosan nanoparticles using a spray-drying method. The spray-dried microparticles were then formulated into orally disintegrating tablets (ODTs) using a wet granulation tablet form...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124395/ https://www.ncbi.nlm.nih.gov/pubmed/21720502 http://dx.doi.org/10.2147/IJN.S17900 |
_version_ | 1782207079991214080 |
---|---|
author | Li, Feng-Qian Yan, Cheng Bi, Juan Lv, Wei-Lin Ji, Rui-Rui Chen, Xu Su, Jia-Can Hu, Jin-Hong |
author_facet | Li, Feng-Qian Yan, Cheng Bi, Juan Lv, Wei-Lin Ji, Rui-Rui Chen, Xu Su, Jia-Can Hu, Jin-Hong |
author_sort | Li, Feng-Qian |
collection | PubMed |
description | Scopolamine hydrobromide (SH)-loaded microparticles were prepared from a colloidal fluid containing ionotropic-gelated chitosan nanoparticles using a spray-drying method. The spray-dried microparticles were then formulated into orally disintegrating tablets (ODTs) using a wet granulation tablet formation process. A drug entrapment efficiency of about 90% (w/w) and loading capacity of 20% (w/w) were achieved for the microparticles, which ranged from 2 μm to 8 μm in diameter. Results of disintegration tests showed that the formulated ODTs could be completely dissolved within 45 seconds. Drug dissolution profiles suggested that SH is released more slowly from tablets made using the microencapsulation process compared with tablets containing SH that is free or in the form of nanoparticles. The time it took for 90% of the drug to be released increased significantly from 3 minutes for conventional ODTs to 90 minutes for ODTs with crosslinked microparticles. Compared with ODTs made with noncrosslinked microparticles, it was thus possible to achieve an even lower drug release rate using tablets with appropriate chitosan crosslinking. Results obtained indicate that the development of new ODTs designed with crosslinked microparticles might be a rational way to overcome the unwanted taste of conventional ODTs and the side effects related to SH’s intrinsic characteristics. |
format | Online Article Text |
id | pubmed-3124395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-31243952011-06-29 A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets Li, Feng-Qian Yan, Cheng Bi, Juan Lv, Wei-Lin Ji, Rui-Rui Chen, Xu Su, Jia-Can Hu, Jin-Hong Int J Nanomedicine Original Research Scopolamine hydrobromide (SH)-loaded microparticles were prepared from a colloidal fluid containing ionotropic-gelated chitosan nanoparticles using a spray-drying method. The spray-dried microparticles were then formulated into orally disintegrating tablets (ODTs) using a wet granulation tablet formation process. A drug entrapment efficiency of about 90% (w/w) and loading capacity of 20% (w/w) were achieved for the microparticles, which ranged from 2 μm to 8 μm in diameter. Results of disintegration tests showed that the formulated ODTs could be completely dissolved within 45 seconds. Drug dissolution profiles suggested that SH is released more slowly from tablets made using the microencapsulation process compared with tablets containing SH that is free or in the form of nanoparticles. The time it took for 90% of the drug to be released increased significantly from 3 minutes for conventional ODTs to 90 minutes for ODTs with crosslinked microparticles. Compared with ODTs made with noncrosslinked microparticles, it was thus possible to achieve an even lower drug release rate using tablets with appropriate chitosan crosslinking. Results obtained indicate that the development of new ODTs designed with crosslinked microparticles might be a rational way to overcome the unwanted taste of conventional ODTs and the side effects related to SH’s intrinsic characteristics. Dove Medical Press 2011 2011-04-28 /pmc/articles/PMC3124395/ /pubmed/21720502 http://dx.doi.org/10.2147/IJN.S17900 Text en © 2011 Li et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Li, Feng-Qian Yan, Cheng Bi, Juan Lv, Wei-Lin Ji, Rui-Rui Chen, Xu Su, Jia-Can Hu, Jin-Hong A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
title | A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
title_full | A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
title_fullStr | A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
title_full_unstemmed | A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
title_short | A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
title_sort | novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124395/ https://www.ncbi.nlm.nih.gov/pubmed/21720502 http://dx.doi.org/10.2147/IJN.S17900 |
work_keys_str_mv | AT lifengqian anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT yancheng anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT bijuan anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT lvweilin anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT jiruirui anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT chenxu anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT sujiacan anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT hujinhong anovelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT lifengqian novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT yancheng novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT bijuan novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT lvweilin novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT jiruirui novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT chenxu novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT sujiacan novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets AT hujinhong novelspraydriednanoparticlesinmicroparticlessystemforformulatingscopolaminehydrobromideintoorallydisintegratingtablets |